.png)
“Accelerating Patient Enrollment Through Embedded Clinical Research Sites”
​
Research Management Partners (RMP) is structured to support Sponsors and CROs seeking consistent study execution, reduced operational risk, and scalable site performance.
Unlike fragmented site networks or software-only SMO models, RMP combines centralized governance with embedded, on-site execution within active clinical practices—ensuring operational control, standardization, and real-time oversight across all participating sites.
Through our embedded SMO framework, sponsors benefit from:
-
Standardized SOP implementation across all sites
-
Continuous quality control and centralized oversight
-
Direct access to diverse, pre-qualified patient populations (>100K patients across our MSO network)
This model enables predictable study timelines, strong enrollment performance, and reliable trial execution at scale.
Our Operational Model
-
Unified SOP governance across all affiliated sites
-
Centralized regulatory and quality oversight
-
Embedded execution within active medical clinics
Performance & KPIs
-
Accelerated IRB submissions (typically 1–2 weeks)
-
Predictable site activation timelines
-
High patient retention driven by continuity of care
-
Rapid query resolution and audit readiness
Therapeutic Scope & Research Capabilities
Research Management Partners (RMP) supports clinical research across a broad range of therapeutic areas through its network of affiliated investigators, medical specialists, and active clinical practices.
Because RMP operates through an embedded SMO model within multi-specialty medical clinics, our network is capable of supporting clinical trials across diverse therapeutic indications depending on sponsor requirements and investigator expertise.
Our investigators have participated in studies involving, but not limited to:
​
• Psychiatry and Behavioral Health
• Gastroenterology
• Pulmonology and Respiratory Diseases
• Internal Medicine
• Rheumatology and Autoimmune Disorders
• Cardiology
• Endocrinology and Metabolic Conditions
• Infectious Diseases
• Dermatology
• Nephrology and Metabolic Disorders
​
In addition to interventional and observational clinical trials, RMP sites can also support biospecimen and sample collection studies, patient registries, and other research programs involving human participants.
Through access to diverse patient populations and integrated clinical care environments, RMP enables sponsors to conduct studies efficiently while maintaining high standards of patient safety, protocol compliance, and data integrity.
Network Performance & Operational Metrics
-
30+ Active Clinical Sites embedded within established medical practices across Florida and Puerto Rico
-
70+ Investigators and Sub-Investigators across key therapeutic areas
-
Access to 100k+ Patients through MSO-supported clinical networks, including 340B-aligned populations, across affiliated medical practices
-
2–4 Week Average Start-Up Timeline from receipt of complete regulatory package to site activation
-
Phase II–IV Focus with scalable multi-site execution capabilities
-
Real-Time Patient Identification leveraging EMR-based pre-screening aligned with protocol-specific criteria
-
Physician-Led Recruitment Model utilizing established patient-provider relationships to improve enrollment and retention
-
Centralized CTMS Oversight enabling real-time performance monitoring and data quality control across all sites
-
Standardized SOP Framework implemented across the network to ensure consistency, compliance, and audit readiness
-
Twice-Monthly On-Site Quality Control (QC) to proactively minimize protocol deviations and ensure operational excellence
-
Access to Diverse and Underserved Populations across South Florida and Puerto Rico, supporting inclusive trial enrollment
-
Single Point of Coordination allowing sponsors and CROs to manage multiple sites through one centralized operational structure
SPONSOR VALUE
Our embedded SMO model reduces monitoring burden while enhancing operational control, protocol compliance, and data reliability across all sites. Through centralized oversight and continuous on-site execution, RMP delivers predictable enrollment performance, improved data integrity, and scalable multi-site trial execution—reducing operational risk and accelerating study timelines.
Supporting sponsors and CROs with reliable execution, scalable infrastructure, and consistent site performance across diverse patient populations.
Case Study: Accelerated Patient Enrollment Through Embedded Site Network
A multi-site clinical study requiring rapid patient enrollment was supported through the RMP embedded SMO network across South Florida. Leveraging direct access to pre-existing patient populations within active medical practices, sites were able to initiate targeted pre-screening immediately upon study activation.
Using EMR-based identification aligned with protocol-specific criteria, combined with physician-led recruitment and centralized CTMS oversight, RMP enabled efficient patient identification and engagement across participating sites.
This approach resulted in consistent screening activity, improved patient retention, and predictable enrollment performance, while maintaining strong protocol compliance and data quality standards throughout the study lifecycle.
“Sites initiated screening activity within the first weeks of activation”
REDUCED MONITORING BURDEN
Our centralized oversight model optimizes study supervision across all affiliated sites, reducing monitoring burden for sponsors and CROs while strengthening protocol compliance, ensuring operational consistency, and consistently delivering high-quality, reliable study outcomes.
Fewer Protocol Deviations
Standardized operational processes and continuous quality oversight across affiliated sites help minimize protocol deviations and ensure consistent protocol adherence throughout study execution.
Reliable Enrollment Forecasts
Our data-driven feasibility and patient-pool analytics enable realistic and dependable enrollment projections. By leveraging EMR-supported population insights and continuous site-level oversight, RMP provides sponsors with predictable recruitment timelines, reduced uncertainty, and greater confidence in study planning and execution.
SCALABLE MULTI-SITE EXECUTION
RMP’s embedded SMO model enables seamless execution of clinical trials across a network of integrated clinical sites through a unified operational infrastructure. Acting as a single point of coordination for sponsors and CROs, RMP delivers centralized governance, ensuring consistent quality control and standardized study execution across all participating sites.
Our integrated framework aligns sites under a common set of SOPs, centralized oversight, and real-time operational visibility. This approach minimizes start-up variability, accelerates site readiness, and enables efficient study scaling across a high-performing network—while maintaining the highest standards of protocol compliance, data integrity, and patient safety.
Study Start-Up & Operational Capabilities
Research Management Partners (RMP) maintains a structured operational framework designed to support efficient clinical trial activation and consistent study execution across our affiliated research sites.
Through centralized oversight and standardized operational procedures, our team works closely with investigators and site staff to ensure smooth study start-up and reliable study conduct.
Operational Capabilities
• Rapid feasibility response and sponsor communication
• Efficient regulatory document collection
• Standardized study start-up procedures across network sites
• Centralized oversight of study conduct and protocol compliance
• Support for investigator training and study preparation
• Continuous monitoring of operational performance across sites
​
​
Our embedded SMO structure allows RMP to deliver predictable activation timelines, strong site engagement, and consistent study performance for sponsors and CRO partners.
Location
Miami, Florida.
Phone
786-464-0868